{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:21:05Z","timestamp":1795173665554,"version":"4.10.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Program of Guangzhou","award":["2023A04J0432"],"award-info":[{"award-number":["2023A04J0432"]}]},{"name":"Science and Technology Program of Guangzhou","award":["No. SL2023A04J02156"],"award-info":[{"award-number":["No. SL2023A04J02156"]}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82200604"],"award-info":[{"award-number":["82200604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"President Foundation of Zhujiang Hospital, Southern Medical University","award":["No. Yzjj2022qn13"],"award-info":[{"award-number":["No. Yzjj2022qn13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03978-w","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:41:49Z","timestamp":1756208509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of different lymph node classification systems as independent prognosticators in gastric signet ring cell carcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Li-Feng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-740X","authenticated-orcid":false,"given":"Yi-Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"3","key":"3978_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3978_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1309\/A09ERYMFR64NERDW","volume":"121","author":"PG Chu","year":"2004","unstructured":"Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121(6):884\u201392.","journal-title":"Am J Clin Pathol"},{"key":"3978_CR3","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.2147\/CMAR.S188622","volume":"11","author":"J Machlowska","year":"2019","unstructured":"Machlowska J, Puculek M, Sitarz M, Terlecki P, Maciejewski R, Sitarz R. State of the Art for gastric signet ring cell carcinoma: from classification, prognosis, and genomic characteristics to specified treatments. Cancer Manag Res. 2019;11:2151\u201361.","journal-title":"Cancer Manag Res"},{"issue":"5","key":"3978_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/jso.24377","volume":"114","author":"T Imamura","year":"2016","unstructured":"Imamura T, Komatsu S, Ichikawa D, Kawaguchi T, Kosuga T, Okamoto K, et al. Early signet ring cell carcinoma of the stomach is related to favorable prognosis and low incidence of lymph node metastasis. J Surg Oncol. 2016;114(5):607\u201312.","journal-title":"J Surg Oncol"},{"issue":"1","key":"3978_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal AJCEBP. Global cancer incidence and mortality rates and Trends\u2014An update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16\u201327.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"40","key":"3978_CR6","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.3748\/wjg.v21.i40.11428","volume":"21","author":"S Pernot","year":"2015","unstructured":"Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428\u201338.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3978_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s10120-015-0564-2","volume":"19","author":"T Voron","year":"2016","unstructured":"Voron T, Messager M, Duhamel A, Lefevre J, Mabrut JY, Goere D, et al. Is signet-ring cell carcinoma a specific entity among gastric cancers? Gastric Cancer. 2016;19(4):1027\u201340.","journal-title":"Gastric Cancer"},{"issue":"1","key":"3978_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.asjsur.2020.03.017","volume":"44","author":"L Wang","year":"2021","unstructured":"Wang L, Hirano Y, Heng G, Ishii T, Kondo H, Hara K, et al. Does signet ring cell carcinoma component signify worse outcomes for patients with colorectal cancer? Asian J Surg. 2021;44(1):105\u201310.","journal-title":"Asian J Surg"},{"key":"3978_CR9","doi-asserted-by":"crossref","unstructured":"Giampieri R, Baleani MG, Bittoni A, Rastelli F, Catalano V, Del Prete M et al. Impact of Signet-Ring cell histology in the management of patients with Non-Metastatic gastric cancer: results from a retrospective multicenter analysis comparing FLOT perioperative chemotherapy vs. surgery followed by adjuvant chemotherapy. Cancers. 2023;15(13):3342.","DOI":"10.3390\/cancers15133342"},{"issue":"6","key":"3978_CR10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/SLA.0b013e3181b21c7b","volume":"250","author":"G Piessen","year":"2009","unstructured":"Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg. 2009;250(6):878\u201387.","journal-title":"Ann Surg"},{"issue":"2","key":"3978_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10120-018-0860-8","volume":"22","author":"YC Kao","year":"2019","unstructured":"Kao YC, Fang WL, Wang RF, Li FY, Yang MH, Wu CW, et al. Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer. Gastric Cancer. 2019;22(2):255\u201363.","journal-title":"Gastric Cancer"},{"issue":"4","key":"3978_CR12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s12253-017-0198-2","volume":"23","author":"K Liu","year":"2017","unstructured":"Liu K, Wan J, Bei Y, Chen X, Lu M. Prognostic impact of different histological types on gastric adenocarcinoma: a surveillance, epidemiology, and end results database analysis. Pathol Oncol Research: POR. 2017;23(4):881\u20137.","journal-title":"Pathol Oncol Research: POR"},{"issue":"17","key":"3978_CR13","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.7150\/jca.21017","volume":"8","author":"RC Nie","year":"2017","unstructured":"Nie RC, Yuan SQ, Li YF, Chen YM, Chen XJ, Zhu BY, et al. Clinicopathological characteristics and prognostic value of signet ring cells in gastric carcinoma: A Meta-Analysis. J Cancer. 2017;8(17):3396\u2013404.","journal-title":"J Cancer"},{"issue":"5","key":"3978_CR14","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/SLA.0000000000001793","volume":"265","author":"HJ Chon","year":"2017","unstructured":"Chon HJ, Hyung WJ, Kim C, Park S, Kim JH, Park CH, et al. Differential prognostic implications of gastric signet ring cell carcinoma: stage adjusted analysis from a single High-volume center in Asia. Ann Surg. 2017;265(5):946\u201353.","journal-title":"Ann Surg"},{"issue":"2","key":"3978_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3904\/kjim.1987.2.2.273","volume":"2","author":"SK Yoon","year":"1987","unstructured":"Yoon SK, Choi SW, Lee CD, Sun HS, Park DH, Kim BS, et al. Pure signet ring cell type early gastric carcinoma with extensive lymph node metastases-a case report. Korean J Intern Med. 1987;2(2):273\u201372.","journal-title":"Korean J Intern Med"},{"issue":"4","key":"3978_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s13193-019-00978-7","volume":"10","author":"K Matsuoka","year":"2019","unstructured":"Matsuoka K, Ueda M, Miyamoto Y. Occult multiple mediastinal lymph node metastasis and malignant pleural effusion due to signet ring cell gastric cancer. Indian J Surg Oncol. 2019;10(4):685\u20137.","journal-title":"Indian J Surg Oncol"},{"issue":"10","key":"3978_CR17","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/MEG.0b013e32832a21d8","volume":"21","author":"JM Park","year":"2009","unstructured":"Park JM, Kim SW, Nam KW, Cho YK, Lee IS, Choi MG, et al. Is it reasonable to treat early gastric cancer with signet ring cell histology by endoscopic resection? Analysis of factors related to lymph-node metastasis. Eur J Gastroenterol Hepatol. 2009;21(10):1132\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5\u20136","key":"3978_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000518898","volume":"38","author":"SH Jeong","year":"2021","unstructured":"Jeong SH, Kim JW, Kim HM. Prevalence of regional lymph node metastasis of mucosal gastric signet ring cell carcinoma: analysis of the collaborative stage data survey of the Korean central cancer registry. Dig Surg. 2021;38(5\u20136):330\u20136.","journal-title":"Dig Surg"},{"issue":"6","key":"3978_CR19","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1097\/SLA.0000000000001602","volume":"264","author":"JH Pyo","year":"2016","unstructured":"Pyo JH, Shin CM, Lee H, Min BH, Lee JH, Kim SM, et al. A risk-prediction model based on lymph-node metastasis for incorporation into a treatment algorithm for signet ring cell-type intramucosal gastric cancer. Ann Surg. 2016;264(6):1038\u201343.","journal-title":"Ann Surg"},{"issue":"4","key":"3978_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10120-016-0645-x","volume":"20","author":"YH Kim","year":"2017","unstructured":"Kim YH, Park JH, Park CK, Kim JH, Lee SK, Lee YC, et al. Histologic purity of signet ring cell carcinoma is a favorable risk factor for lymph node metastasis in poorly cohesive, submucosa-invasive early gastric carcinoma. Gastric Cancer. 2017;20(4):583\u201390.","journal-title":"Gastric Cancer"},{"issue":"4","key":"3978_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10120-018-00905-9","volume":"22","author":"K Murai","year":"2019","unstructured":"Murai K, Takizawa K, Shimoda T, Fujii S, Sugino T, Yoshida M, et al. Effect of double-layer structure in intramucosal gastric signet-ring cell carcinoma on lymph node metastasis: a retrospective, single-center study. Gastric Cancer. 2019;22(4):751\u20138.","journal-title":"Gastric Cancer"},{"key":"3978_CR22","unstructured":"AJCC cancer staging manual. 8th ed. New York: Springer; 2017. XVII, 1032 p."},{"issue":"12","key":"3978_CR23","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1245\/s10434-017-6078-x","volume":"24","author":"H In","year":"2017","unstructured":"In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T. Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the National cancer database. Ann Surg Oncol. 2017;24(12):3683\u201391.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3978_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10120-016-0601-9","volume":"20","author":"T Sano","year":"2017","unstructured":"Sano T, Coit DG, Kim HH, Roviello F, Kassab P, Wittekind C, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: international gastric cancer association staging project. Gastric Cancer. 2017;20(2):217\u201325.","journal-title":"Gastric Cancer"},{"issue":"28","key":"3978_CR25","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1200\/JCO.2005.14.621","volume":"23","author":"DD Smith","year":"2005","unstructured":"Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncology: Official J Am Soc Clin Oncol. 2005;23(28):7114\u201324.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"2","key":"3978_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/sj.bjc.6600432","volume":"87","author":"G de Manzoni","year":"2002","unstructured":"de Manzoni G, Verlato G, Roviello F, Morgagni P, Di Leo A, Saragoni L, et al. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer. 2002;87(2):171\u20134.","journal-title":"Br J Cancer"},{"issue":"10","key":"3978_CR27","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1046\/j.0007-1323.2001.01875.x","volume":"88","author":"HK Lee","year":"2001","unstructured":"Lee HK, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP. Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg. 2001;88(10):1408\u201312.","journal-title":"Br J Surg"},{"issue":"25","key":"3978_CR28","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1056\/NEJM198506203122504","volume":"312","author":"AR Feinstein","year":"1985","unstructured":"Feinstein AR, Sosin DM, Wells CK. The will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"3978_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/SLA.0b013e31821d4d75","volume":"255","author":"SH Kong","year":"2012","unstructured":"Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, et al. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg. 2012;255(1):50\u20138.","journal-title":"Ann Surg"},{"issue":"5","key":"3978_CR30","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1245\/s10434-010-0914-6","volume":"17","author":"UN Maduekwe","year":"2010","unstructured":"Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, et al. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2010;17(5):1267\u201377.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"3978_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/jso.25411","volume":"119","author":"A Agnes","year":"2019","unstructured":"Agnes A, Biondi A, Cananzi FM, Rausei S, Reddavid R, Laterza V, et al. Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: A multicenter retrospective study. J Surg Oncol. 2019;119(7):948\u201357.","journal-title":"J Surg Oncol"},{"issue":"2","key":"3978_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1245\/s10434-008-0240-4","volume":"16","author":"DZ Xu","year":"2009","unstructured":"Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W, Zhou ZW, et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16(2):319\u201326.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3978_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejso.2004.09.013","volume":"31","author":"JM Rodr\u00edguez Santiago","year":"2005","unstructured":"Rodr\u00edguez Santiago JM, Mu\u00f1oz E, Mart\u00ed M, Quintana S, Veloso E, Marco C. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2005;31(1):59\u201366.","journal-title":"Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"4","key":"3978_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/01.sla.0000250423.43436.e1","volume":"245","author":"A Marchet","year":"2007","unstructured":"Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007;245(4):543\u201352.","journal-title":"Ann Surg"},{"issue":"11","key":"3978_CR35","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/cncr.24989","volume":"116","author":"Z Sun","year":"2010","unstructured":"Sun Z, Xu Y, Li de M, Wang ZN, Zhu GL, Huang BJ, et al. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer. 2010;116(11):2571\u201380.","journal-title":"Cancer"},{"issue":"7","key":"3978_CR36","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s11605-014-2539-8","volume":"18","author":"P Aurello","year":"2014","unstructured":"Aurello P, Petrucciani N, Nigri GR, La Torre M, Magistri P, Tierno S, et al. Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma? J Gastrointest Surgery: Official J Soc Surg Aliment Tract. 2014;18(7):1254\u201360.","journal-title":"J Gastrointest Surgery: Official J Soc Surg Aliment Tract"},{"issue":"8","key":"3978_CR37","doi-asserted-by":"publisher","first-page":"11105","DOI":"10.1007\/s13277-015-4191-7","volume":"37","author":"C Jian-Hui","year":"2016","unstructured":"Jian-Hui C, Shi-Rong C, Hui W, Si-le C, Jian-Bo X, Er-Tao Z, et al. Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy. Tumour Biology: J Int Soc Oncodevelopmental Biology Med. 2016;37(8):11105\u201313.","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"issue":"21","key":"3978_CR38","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Research: Official J Am Association Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"2","key":"3978_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J Royal Stat Soc Ser B (Methodological). 1972;34(2):187\u2013220.","journal-title":"J Royal Stat Soc Ser B (Methodological)"},{"issue":"2","key":"3978_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337\u201344.","journal-title":"Biometrics"},{"issue":"14","key":"3978_CR41","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, et al. Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature. JAMA. 2017;318(14):1377\u201384.","journal-title":"JAMA"},{"issue":"7","key":"3978_CR42","doi-asserted-by":"publisher","first-page":"765","DOI":"10.5858\/2004-128-765-DTITIA","volume":"128","author":"DE Henson","year":"2004","unstructured":"Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the united states, 1973\u20132000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128(7):765\u201370.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"3978_CR43","first-page":"1299","volume":"17","author":"H Cao","year":"2019","unstructured":"Cao H, Tang Z, Yu Z, Wang Q, Li Z, Lu Q, et al. Comparison of the 8th union for international cancer control lymph node staging system for gastric cancer with two other lymph node staging systems. Oncol Lett. 2019;17(1):1299\u2013305.","journal-title":"Oncol Lett"},{"issue":"1","key":"3978_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamasurg.2014.678","volume":"150","author":"JW Morgan","year":"2015","unstructured":"Morgan JW, Ji L, Friedman G, Senthil M, Dyke C, Lum SS. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery. JAMA Surg. 2015;150(1):37\u201343.","journal-title":"JAMA Surg"},{"issue":"5","key":"3978_CR45","first-page":"477","volume":"30","author":"J Deng","year":"2018","unstructured":"Deng J, Liu J, Wang W, Sun Z, Wang Z, Zhou Z, et al. Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American joint committee on cancer (AJCC) TNM staging system. Chin J Cancer Res = Chung-kuo Yen Cheng Yen Chiu. 2018;30(5):477\u201391.","journal-title":"Chin J Cancer Res = Chung-kuo Yen Cheng Yen Chiu"},{"issue":"23","key":"3978_CR46","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.7150\/jca.30979","volume":"10","author":"W Zhang","year":"2019","unstructured":"Zhang W, Zhangyuan G, Wang J, Jin K, Liu Y, Wang F, et al. Effect of lymph nodes count in node-positive gastric cancer. J Cancer. 2019;10(23):5646\u201353.","journal-title":"J Cancer"},{"issue":"6","key":"3978_CR47","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ejso.2015.03.227","volume":"41","author":"A Biondi","year":"2015","unstructured":"Biondi A, D\u2019Ugo D, Cananzi FC, Papa V, Borasi A, Sicoli F, et al. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2015;41(6):779\u201386.","journal-title":"Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"2","key":"3978_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2022;20(2):167\u201392.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"9","key":"3978_CR49","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s11605-023-05735-4","volume":"27","author":"FB Maegawa","year":"2023","unstructured":"Maegawa FB, Patel AD, Serrot FJ, Patel SG, Stetler JL, Patel DC, et al. Gastric cancer surgery in the US: a contemporary trend analysis of lymphadenectomy and the impact of minimally invasive approaches. J Gastrointest Surgery: Official J Soc Surg Aliment Tract. 2023;27(9):1825\u201336.","journal-title":"J Gastrointest Surgery: Official J Soc Surg Aliment Tract"},{"issue":"4","key":"3978_CR50","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1245\/s10434-014-4121-8","volume":"22","author":"J Deng","year":"2015","unstructured":"Deng J, Zhang R, Wu L, Zhang L, Wang X, Liu Y, et al. Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer. Ann Surg Oncol. 2015;22(4):1258\u201366.","journal-title":"Ann Surg Oncol"},{"issue":"1\u20134","key":"3978_CR51","first-page":"1","volume":"53","author":"L Lorenzon","year":"2014","unstructured":"43, Lorenzon L, Mercantini P, Ferri M, La Torre M, Sparagna A, Balducci G, et al. Lymph-node ratio classification strongly correlates with cancer survivals of patients who underwent r0 resection for gastric cancer with more than 15 nodes harvested. Eur Surg Res Europaische Chirurgische Forschung Recherches Chirurgicales Europeennes. 2014;53(1\u20134):1\u201310.","journal-title":"Eur Surg Res Europaische Chirurgische Forschung Recherches Chirurgicales Europeennes"},{"issue":"10","key":"3978_CR52","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1007\/s11605-008-0651-3","volume":"12","author":"J Wang","year":"2008","unstructured":"Wang J, Hassett JM, Dayton MT, Kulaylat MN. The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surgery: Official J Soc Surg Aliment Tract. 2008;12(10):1790\u20136.","journal-title":"J Gastrointest Surgery: Official J Soc Surg Aliment Tract"},{"issue":"13","key":"3978_CR53","doi-asserted-by":"publisher","first-page":"8937","DOI":"10.1245\/s10434-021-10299-1","volume":"28","author":"K Che","year":"2021","unstructured":"Che K, Wang Y, Wu N, Liu Q, Yang J, Liu B, et al. Prognostic nomograms based on three lymph node classification systems for resected gastric adenocarcinoma: A large Population-Based cohort study and external validation. Ann Surg Oncol. 2021;28(13):8937\u201349.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3978_CR54","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/j.clgc.2022.12.001","volume":"21","author":"A Salari","year":"2023","unstructured":"Salari A, Ghahari M, Nowroozi A, Ghahari P, Haddad M, Sahebi L, et al. Log odds of positive lymph nodes (LODDS) as an independent predictor of overall survival following radical cystectomy in urothelial bladder cancer: time to rethink conventional node staging. Clin Genitourin Cancer. 2023;21(3):e175\u201381.","journal-title":"Clin Genitourin Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03978-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03978-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03978-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:02:49Z","timestamp":1761692569000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03978-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3978"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03978-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated: Funding grant number \"No. SL2023A04J02156 \" has been updated to \"2024A04J4877\".","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patient data extracted and case lists constructed from the SEER database, are anonymous and shared, without containing any identifiers. For this reason, this study was exempted from approval by the institutional review board of Zhujiang Hospital of Southern Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}